Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this FDA Warning Letter issued to Malanda, Inc. operating as Mandell's Clinical Pharmacy in June 2020 concerns drug product violations. Without access to the full warning letter text or detailed subject information, the specific nature of the violations cannot be determined from the available metadata. The letter falls under FDA's drug product regulatory authority, though the issuing office and exact violation count are not specified in the metadata provided.